Global RNAi Therapeutics Market: Size, Trends & Forecast Impact Analysis of COVID-19 (2022-2026)

The key players of the global RNAi therapeutics market are Moderna Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., and Silence Therapeutics Inc. are also profiled with their financial information and respective business strategies.
 
DELHI, India - March 28, 2022 - PRLog -- he report provides an in depth analysis of the Global RNAi therapeutics market by value, by molecule type, by application, by region, etc. The report provides a regional analysis of the RNAi therapeutics market, including North America (The US, Canada, and Mexico), Europe, Asia Pacific, Middle East & Africa, and Latin America. The report further provides the detailed analysis of the US market on the basis of molecule type, and application. The report also provides an analysis of the COVID-19 impact on the RNAi therapeutics market.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall RNAi therapeutics market has also been forecasted for the period 2022-2026, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Company Coverage

Moderna Inc.
Alnylam Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Silence Therapeutics Inc.

Regional Coverage

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Executive Summary

The RNAi therapeutics market can be segmented on the basis of molecule type (small interference RNA (siRNA), and micro RNA (miRNA)), and application (oncology, cardiovascular disorders, respiratory disorders, renal diseases, genetic disorders, neurodegenerative disorders, infectious diseases, and others).

While most of the industries worldwide suffered a negative impact of COVID-19, the RNAi therapeutics market witnessed a positive impact on it. Initially, the market witnessed a sudden spike in the demand, since the relevance of RNAi research in understanding the COVID-19 virus started growing mainly during the initial worldwide outbreak of COVID-19, in 2020. Later in the year 2020, the market witnessed several investments from both public and private investors in pharma R&D laboratories to conduct various studies and experiments to find out vaccines to prevent the spread of virus.

The global RNAi therapeutics market has increased during the years 2020-2021 and projections are made that the market would rise in the next four years i.e. 2022-2026. The global RNAi therapeutics market is expected to increase due to significant increase in investment, increased prevalence of infectious diseases, rise in incidence of cancer, rising prevalence of diabetes, and rising genetic and metabolic disorders.

For further details, kindly visit :

https://www.daedal-research.com/pharma-healthcare/global-rnai-therapeutics-market-size-trends-forecast-with-impact-analysis-of-covid-19-2022-2026

Rajeev Kumar

(Business Development Manager)

Address:  36 SFS Flats

Paschim Vihar

New Delhi-110063

Mobile: +91-9811715635

Tel: +91-120-4553017

Mail ID - info@daedal-research.com

Contact
Rajeev Kumar
info@daedal-research.com
+91-9811715635
End
Source: » Follow
Email:***@daedal-research.com Email Verified
Tags:RNAi therapeutics market
Industry:Reports
Location:Delhi - Delhi - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Daedal Research PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share